Medical research

Study pinpoints molecular targets of transplant rejection

Researchers from the University of Sydney and Monash University have made a significant discovery that uncovers what is happening at the molecular level when an organ transplant is recognized as foreign by the immune system.

Medications

Rapamune approved for rare lung disease

(HealthDay)—Rapamune (sirolimus) has been approved by the U.S. Food and Drug Administration to treat a rare, progressive lung disease that mostly affects women of childbearing age.

page 6 from 11